Lesinurad Tablet Relative Bioavailability

Inclusion Criteria: * Subject has a body weight ≥ 50 kg (110 lbs) and a body mass index (BMI) ≥ 18 and ≤ 40 kg/m2. * Subject has a Screening sUA value ≤ 7.0 mg/dL. * Subject is free of any clinically significant disease that requires a physician's care and/or would interfere with study evaluations or procedures. * Subject has no clinically relevant abnormalities in vital signs, ECG, physical examination or safety laboratory values per the Investigator's judgment. Exclusion Criteria: * Subject has a history or clinical manifestations of significant metabolic, hematological, pulmonary, cardiovascular, gastrointestinal, neurologic, hepatic, renal, urological, or psychiatric disorders. * Subject has a history or suspicion of kidney stones. * Subject has a history of asthma. * Subject has undergone major surgery within 3 months prior to Day 1. * Subject has donated blood or experienced significant blood loss (\> 450 mL) within 12 weeks prior to Day 1 or gave a plasma donation within 4 weeks prior to the Screening visit. * Subject has inadequate venous access or unsuitable veins for repeated venipuncture.